CorMedix announced that it has entered into a new commercial supply contract with a top-tier mid-sized dialysis operator for the supply of DefenCath to dialysis clinics in the US. This new agreement will provide access to DefenCath for adult patients with kidney failure receiving hemodialysis through a central venous catheter at more than 250 outpatient dialysis clinics located across the United States.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRMD:
Questions or Comments about the article? Write to editor@tipranks.com